Synchronized cardioversion is a low energy shock that uses a sensor to provide electricity that is synchronized with the highest point of the QRS complex.
Synchronized Cardioversion Market: Introduction
- Synchronized cardioversion is a low energy shock that uses a sensor to provide electricity that is synchronized with the highest point of the QRS complex. The shock dose used for a synchronized shock is lower than that used for defibrillation.
Read Report Overview - https://www.transparencymarketresearch.com/synchronized-cardioversion-market.html
- During the delay, when the sync option is engaged on a defibrillator and the shock button pushed, the machine reads and synchronizes with the patient’s ECG rhythm. Synchronized cardioversion evades shock delivery during the relative refractory portion of the cardiac cycle, when a shock could produce ventricular fibrillation.
- Synchronized cardioversion is primarily used to treat atrial fibrillation when anti-arrhythmic drugs have failed to do so and to treat atrial fibrillation in emergency conditions where this condition is causing heart failure, chest pain, or low blood pressure
Key Drivers, Restrains, and Opportunities of Global Synchronized Cardioversion Market
- Rise in number of people with chronic diseases such as cardiovascular diseases, diabetes and obesity, technologically advanced procedures adopted by hospitals and clinics, and increase in global geriatric population leading to a surge in incidence rate of atrial fibrillation are likely to drive the global synchronized cardioversion market during the forecast period
- According to the World Health Organization (WHO), cardiovascular disease accounts for nearly 17.9 million deaths every year, which is estimated to account for 31% of all global deaths
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=45459
- According to the International Diabetes Federation (IDF), nearly 463 million adults (20 to 79 years) were living with diabetes in 2019, and the number is projected to reach 700 million by 2045
- According to the World Health Organization (WHO), the population of people aged 60 years and above is projected to rise from 900 million in 2015 to 2 billion in 2050. Increase in geriatric population leads to a surge in incidence of age-related problems such as cardiovascular diseases and respiratory diseases. This is anticipated to boost the global resuscitation device market.
- However, skilled and trained personnel is required for the clinical application of synchronized cardioversion, which is a major restraint of the global market
- The world is currently experiencing the pandemic of an infectious disease called COVID-19. This infection leads to multiple organ failure, acute & severe respiratory disorders, pneumonia, and even death in severe cases. Thus, a surge in number of patients with severe COVID-19 infection has fueled the demand for synchronized cardioversion. The geriatric population is more prone to COVID-19, which is likely to drive the market.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=45459
North America to Capture Major Share of Global Synchronized Cardioversion Market
- In terms of region, the global synchronized cardioversion market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America is a significant market for synchronized cardioversion in 2020, and the trend is expected to continue during the forecast period. North America’s dominance of the global market is attributed to an increase in adoption of technologically advanced products and rise in incidence of heart diseases. According to the Centers for Disease Control and Prevention, heart diseases account for about 647,000 deaths in the U.S. each year, i.e., 1 in every 4 deaths. According to the Centers for Disease Control and Prevention (CDC), approximately every 40 seconds an American is likely to experience a heart attack. Every year, 805,000 people in the U.S. have a heart attack; 605,000 of them for the first time.
- Europe was also a significant market for synchronized cardioversion in 2020, due to an increase in government initiatives and a rise in prevalence of cardiovascular diseases. According to the European Heart Network, each year, cardiovascular diseases causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union.
- Increase in number of people with common diseases such as diabetes and obesity, aging population, rise in awareness about overall health, and surge in healthcare expenditure are projected to boost the synchronized cardioversion market in Asia Pacific during the forecast period
- Regions such as Latin America and Middle East & Africa are likely to be lucrative markets for synchronized cardioversion during the forecast period because of the initiatives taken by government and non-government organizations in these regions
Pre Book Synchronized Cardioversion Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=45459<ype=S
Key Players Operating in Global Synchronized Cardioversion Market
The global synchronized cardioversion market is highly concentrated due to the presence of key players. A large number of manufacturers hold major share in their respective regions. Demand for products to treat chronic diseases has increased in emerging as well as developed markets. Growth strategies adopted by leading players are likely to drive the global synchronized cardioversion market.
Major players operating in the global synchronized cardioversion market are listed below:
- ZOLL Medical Corporation
- Medtronic
- TZ Medical, Inc.
- Koninklijke Philips N.V.
- ConMed Corporation
Browse more Reports by Transparency Market Research:
Wound Healing Market: The companies engaged in the wound healing market are going through critical scenario owing to the recent COVID-19 pandemic. They are experiencing disruption in production and distribution activities.
Endoscopy Equipment Market: The high demand for the flexible endoscopes is accounting for the dominating share in the global endoscopy devices market, and is expected to continue its dominance over the forecast period.
Stretch Marks Treatment Market: Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women, along with the wide array of products, catering to almost every need and budget, is also positively influencing the market for stretch marks treatment.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/